Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive is supported by a durable international engine that has delivered mid-to-high single-digit organic growth, with Europe adding about 300 bps of toothpaste share since 2016 and emerging markets providing nearly half of sales. Its bull case is further strengthened by Hill’s, which contributes almost one-fourth of revenue, and by margin expansion tied to the Global Growth and Efficiency Program, which targets annual savings of $500–575MM with an after-tax return above 30%. The main overhang is North America, where organic sales have been negative in most of the past two years, but the proven European two-brand playbook suggests the US can stabilize, making the long-term growth profile more attractive.

Colgate-Palmolive is facing a negative fundamental setup because its U.S. business has been a persistent drag, with North America down about 2% over the last 8 quarters and underperforming HPC peers by roughly 250 bps as self-inflicted pricing, marketing, and portfolio missteps hurt share. Competitive pressure is intensifying from P&G and Haleon, whose clinically backed brands are winning higher-income, older consumers while Colgate’s toothpaste portfolio remains priced at a 92 index to category average and more than 50% below Haleon’s average price per unit. Although international sales and Hill’s provide scale, the company’s growth is still offset by weak premium innovation, a late 2025 relaunch of Colgate Total, and downside risk from 2026 cost pressure and currency and commodity volatility.